Metallation of biomacromolecular species forms the basis for the anticancer activity of many metallodrugs. A major limitation of these compounds is that their reactivity is indiscriminate and can, in principle, occur in healthy tissue as well as cancerous tissue, potentially leading to side effects in vivo. Here we present pH-dependent intramolecular coordination of an arene-tethered sulfonamide functionality in organometallic ruthenium(II) ethylenediamine complexes as a route to controlling the coordination environment about the central metal atom. Through variation of the sulfonamide R group and the length of the tether linking it to the arene ligand the acidity of the sulfonamide NH group, and hence the pH-region over which regulation of metal coordination occurs, can be modulated. Intramolecular sulfonamide ligation controlled the reactivity of complex 4 within the physiologically relevant pH-region, rendering it more reactive towards 5 -GMP in mildly acidic pH-conditions typical of tumour tissue compared to the mildly alkaline pH-conditions typical of healthy tissue. However, the activation of 4 by ring-opening of the chelate was found to be a slow process relative to the timescale of typical cell culture assays and members of this series of complexes were found not to be cytotoxic towards the HT-29 cell line. These complexes provide the basis for the development of analogues of increased potency where intramolecular sulfonamide ligation regulates reactivity and therefore cytotoxicity in a pH-dependent, and potentially, tissue-dependent manner.
Introduction
Metallodrugs offer much potential in the development of new chemotherapeutics for the treatment of cancer [1] [2] [3] [4] . The careful choice of the metal ion, controlling properties such as coordination geometry, metal oxidation state and redox chemistry, offers the potential of modes of activity not possible with purely organic chemotherapeutics. Metallodrugs that exert anticancer activity often do so through coordination to a variety of biomacromolecular targets. However, a major limitation is that such coordination can occur in both cancerous and healthy tissue, leading to off-target reactivity that would lead to potentially serious side effects in vivo. Rendering metal-centered reactivity dependent on the local tissue environment could lead to reduced off-target reactivity, for example metallodrugs with increased reactivity in tumors could be devised by exploiting the difference in extracellular pH between healthy (7.2-7.4) and cancerous tissue (6.5-6.9) [5] . Several studies have reported metallodrugs possessing reactivity profiles that fulfil some of these aims where the coordination environment around the central metal atom has been rendered pH-dependent.
Sadler et al. explored the reversible and pH-dependent equilibrium between ring-open and ringclosed forms of bis(aminophosphine) Pt(II) complexes [6, 7] . pH titrations with cis-[PtCl(Me2N(CH2)2PPh2-N,P)(Me2N(CH2)2PPh2-P)]Cl ( Figure 1A ) yielded a pKa value of 6.9 and the equilibrium was also found to be dependent on Cl − concentration. cis-[PtCl (Me2N(CH2) 2PPh2-N,P)(Me2N(CH2)2PPh2-P)]Cl was reported to be active against several cell lines, in conditions in which the open form of the complex would be present, but both cis- [PtCl(Me2N(CH2) 2PPh2-N,P)(Me2N(CH2)2PPh2-P)]Cl and the ring closed form were found to react rapidly with 5ʹ-GMP. This indicates the closed form of the complex is unable to regulate coordination of DNA to the metal center, although coordination of S-donor ligands to Pt(II) was prevented in the ring-closed form of the complex. A series of bis(O-alkyldithiocarbonato)platinum(II) complexes ( Figure 1B ) were found to be more active at pH 6.8 versus 7.4 with average IC50 (pH 7.0)/IC50 (pH 6.8) ratios >2 found across six tumor cell lines for selected complexes [8] . The increase in activity of the complexes at acidic pH was attributed to increased ligand protonation and consequential destabilization of the complex, leading to increased reactivity. A bis(2-aminoethanolato-κ 2 N,O) platinum(II) complex ( Figure 1C ) was also shown to exhibit increased reactivity toward 5ʹ-GMP at pH 6.0 versus pH 7.4 [9] , although reactivity under the latter pH conditions was still appreciable. Reactivity towards DNA was not detected at pH 7.4 but found to be greatly increased at pH 6.0 [10] and cell culture experiments revealed increased cytotoxicity toward the A549 cell line at pH 6.0 versus 7.0 [9] . Platinum(II) complexes based on 1,3-dihydroxyacetone oxime ligands were also shown to exhibit pH-dependent cytotoxicity profiles against the SW480 and A549 cell lines (pH 6.0 versus pH 7.4), again related to a pH-dependent ring-opening activation process to increase the reactivity of the complex [11] . The pH-dependent intramolecular chelation of a range of ligands in half-sandwich ruthenium complexes to regulate ligand coordination at the ruthenium center has also been explored. Scrase et al. reported that a L-2,3-diaminopropionic acid ligand coordinated in a tridentate manner to a ruthenium-η 6 -arene moiety was found to be labilized on lowering of pH, leading to partial reactivity of the complex on incubation with a protected methionine ligand at pH 2.5 [12] . Pizarro et al. have shown reversible intramolecular chelation can be achieved in half-sandwich ruthenium complexes utilizing an hemilabile 2-aminobiphenyl arene ligand [13] . The closed form of the complexes, achieved through an arene ligand η 6 :κ 1 -C6H5(C6H4)NH2 coordination mode ( Figure 1D ), dominates The pH-dependent intramolecular chelation of a range of ligands in half-sandwich ruthenium complexes to regulate ligand coordination at the ruthenium center has also been explored. Scrase et al. reported that a L-2,3-diaminopropionic acid ligand coordinated in a tridentate manner to a ruthenium-η 6 -arene moiety was found to be labilized on lowering of pH, leading to partial reactivity of the complex on incubation with a protected methionine ligand at pH 2.5 [12] . Pizarro et al. have shown reversible intramolecular chelation can be achieved in half-sandwich ruthenium complexes utilizing an hemilabile 2-aminobiphenyl arene ligand [13] . The closed form of the complexes, achieved through an arene ligand η 6 :κ 1 -C 6 H 5 (C 6 H 4 )NH 2 coordination mode ( Figure 1D ), dominates at neutral pH (the pK a value for the pendant amine functionality was found to be ca. 2.5), and were found to be unreactive with respect to coordination to 5 -GMP. The complexes were found to be non-cytotoxic in cell culture experiments, in accordance with the lack of reactivity observed under these pH conditions. Pizarro et al. have also developed ruthenium(II) piano-stool complexes utilizing phenylacetic acid as the arene ligand, enabling a 5-membered intramolecular chelate to be formed via carboxylate O-coordination to ruthenium [14] . Several complexes of the structure [Ru(η 6 -C 6 H 5 CH 2 COOH)(XY)Cl]Cl/Na were devised and -COOH pK a values in the range 2.8-3.5 were reported, indicating the closed form of the complexes predominates under physiologically relevant conditions. Interestingly the closed form of some of the complexes reported were mildly cytotoxic, potentially indicating an alternative cytotoxic mechanism of action to metallodrug-biomacromolecular coordination. In a previous study we evaluated the utility of a pendant sulfonamide functionality in [Ru(η 6 -C 6 H 5 CH 2 CH 2 NHR)(C 2 O 4 )(H 2 O)] (R = Ms, Tf) complexes ( Figure 1E ) to regulate the availability of a coordination site at ruthenium, and subsequently the ligation of 5 -GMP to the metal as a function of pH [15] . We found that modulation of the sulfonamide R group enabled the basicity of the sulfonamide nitrogen to be tuned, and when R=CH 3 the apparent pK a was found to be 6.65. Consequently, coordination of 5 -GMP to ruthenium was found to be able to be controlled across the physiologically relevant pH region. Interestingly, L-histidine coordination was not regulated under these conditions and was found to displace the ligated sulfonamide. This family of complexes therefore offers potential selectivity with respect to ruthenium coordination between different classes of biomacromolecular targets but, due to a lack of pH dependence with respect to L-histidine binding, are unable to differentiate between healthy and cancerous tissue.
In this work we expand the range of half-sandwich ruthenium structures into which pendant sulphonamide functionality has been incorporated. We hypothesized that the introduction of pendant sulfonamide functionality into organometallic structures known to be cytotoxic towards cancer cell lines would regulate their reactivity, and therefore cytotoxicity, in a pH-dependent manner that is not achievable with the original complex. We chose to focus on the [Ru(η 6 -arene)(en)(Cl)]PF 6 (en = ethylenediamine) family of compounds [16] that are known to be cytotoxic towards a range of cancer cell lines with IC 50 values typically in the low µM range [17] . Here we report the synthesis of a series of ruthenium(II)-arene complexes of the type [Ru(η 6 -C 6 H 5 (CH 2 ) n NHR)(en)(Cl)]PF 6 , with pendant sulfonamide or N-acetyl functionality, and evaluate their pH-dependent reactivity in aqueous solution and their cytotoxicity in cell culture experiments.
Results and Discussion

Synthesis and Characterisation
A total of six half-sandwich ruthenium(II) arene complexes were synthesized for evaluation in this study ( Figure 2 ). [Ru(η 6 -C 6 H 5 CH 2 CH 2 NHR)(en)(Cl)]PF 6 (R = Ms (1), tresyl (Tr) (2), Tf (3) or acetyl (6) ) and [Ru(η 6 -C 6 H 5 (CH 2 ) 3 CH 2 NHTf)(en)(Cl)]PF 6 (5) were prepared via reaction of the respective [RuCl 2 (η 6 -C 6 H 5 (CH 2 ) n CH 2 NHR)] 2 (R = acetyl, Ms, Tf or Tr) complex with ethylenediamine followed by the addition of NH 4 PF 6 then crystallization of the product by concentration of the methanol solution or via vapor diffusion with diethyl ether. [Ru(η 6 :κ 1 -C 6 H 5 (CH 2 ) 2 CH 2 NTf)(en)]PF 6 (4) was prepared via the reaction of [RuCl 2 (η 6 -C 6 H 5 (CH 2 ) 2 CH 2 NHTf)] 2 with ethylenediamine then treatment with silver carbonate and triethylamine, followed by addition of NH 4 PF 6 and precipitation of the product by concentration and cooling. All complexes are soluble in water (≥5 mM) and stable in the presence of NaCl (100 mM). All complexes were characterized by 1 H, 13 C and 19 F NMR spectroscopy, high resolution mass spectrometry and elemental analysis. 
Crystallography
Single crystals of 1-6 suitable for single crystal X-ray crystallography were obtained during the crystallization step of the bulk complexes.
The molecular structure of 1 is rather simple as shown in the ORTEP plot in Figure 3a . However, each of the ions present (PF6 − and [RuCl(en)L] + ) lies on one of the mirror planes present in the space group P21/m. For the metal-containing fragment, this mirror plane passes mid-way through the ethylenediamine and mid-way through the arene ligand. The action of the mirror plane generates a second orientation of ligands related to the first by rotation of 23.3 degrees. This provides a beautiful but most unwelcome complication to the modelling of the crystal structure (illustrated in Figure S1 ). Two orientations of all the atoms present except Ru1, Cl1 and C1 are generated by symmetry. The unit cell contains two molecules of the compound related by inversion symmetry. Attempts made to refine the structure in the space group P21 were unsatisfactory and the disorder persisted. The intensity statistics and refinements suggest that the centrosymmetric space group P21/m is correct. N-H···Cl interactions assemble the molecules into tapes that extend along the crystallographic baxis. These interactions are augmented by N-H···F interactions with PF6 anions. 
The molecular structure of 1 is rather simple as shown in the ORTEP plot in Figure 3a . However, each of the ions present (PF 6 − and [RuCl(en)L] + ) lies on one of the mirror planes present in the space group P2 1 /m. For the metal-containing fragment, this mirror plane passes mid-way through the ethylenediamine and mid-way through the arene ligand. The action of the mirror plane generates a second orientation of ligands related to the first by rotation of 23.3 degrees. This provides a beautiful but most unwelcome complication to the modelling of the crystal structure (illustrated in Figure S1 ). Two orientations of all the atoms present except Ru1, Cl1 and C1 are generated by symmetry. The unit cell contains two molecules of the compound related by inversion symmetry. Attempts made to refine the structure in the space group P2 1 were unsatisfactory and the disorder persisted. The intensity statistics and refinements suggest that the centrosymmetric space group P2 1 /m is correct. N-H···Cl interactions assemble the molecules into tapes that extend along the crystallographic b-axis. These interactions are augmented by N-H···F interactions with PF 6 anions. In 2 the Ru is surrounded by the arene, one chloride, and bidentate ethylenediamine. The structure is centrosymmetric and crystallizes in space group P1 with a single complex and one anion in the asymmetric unit as shown in Figure 3b . Adjacent complexes are held together by two N−H···Cl hydrogen bonds from ethylenediamine in a centric R 2 2(8) embrace [18] . There are further N−H···O=S and N−H···Cl interactions between the amide and sulfonamide and chloride. These interactions form tapes of ruthenium complexes that run parallel to the crystallographic a direction. Between the tapes lie PF6 − anions. There are C−H···F interactions between the alkyl chain of the complex and these anions and also between alkyl chain and the CF3 groups. The crystal examined was a non-merohedral twin with the two components related by the twin law (1.01 −0.035 0.012; 0.0534 0.985 0.003; 0.002 −0.01 1.003). The integration process produced intensity data from two domains and overlapping reflections. The structure was refined using all observed data using the HKLF5 formalism within SHELXL. The two domains were present in the ratio 0.622:0.378 (2) .
For 3 ( Figure 4a ) the molecular structure differs from 2 only in the sulfonate group. Here, the CF3 is directly joined to the sulfur rather than a CH2CF3 group being joined to the sulfur. This has a pronounced influence on the interactions between molecules and hence the crystal packing. Coordination about the metal is similar to other examples. The N−H···Cl interactions from the bound ethylenediamine do not occur in this structure; one N−H···O=S hydrogen bond is present. There are N−H (amide)···Cl interactions that form dimers of molecules. These dimers are held into a puckered 2-D network by the N−H···O=S hydrogen bonds. The space between networks is filled by the anions. In 2 the Ru is surrounded by the arene, one chloride, and bidentate ethylenediamine. The structure is centrosymmetric and crystallizes in space group P1 with a single complex and one anion in the asymmetric unit as shown in Figure 3b . Adjacent complexes are held together by two N-H···Cl hydrogen bonds from ethylenediamine in a centric R 2 2 (8) embrace [18] . There are further N-H···O=S and N-H···Cl interactions between the amide and sulfonamide and chloride. These interactions form tapes of ruthenium complexes that run parallel to the crystallographic a direction. Between the tapes lie PF 6 − anions. There are C-H···F interactions between the alkyl chain of the complex and these anions and also between alkyl chain and the CF 3 groups. The crystal examined was a non-merohedral twin with the two components related by the twin law (1.01 −0.035 0.012; 0.0534 0.985 0.003; 0.002 −0.01 1.003). The integration process produced intensity data from two domains and overlapping reflections. The structure was refined using all observed data using the HKLF5 formalism within SHELXL. The two domains were present in the ratio 0.622:0.378 (2) . For 3 ( Figure 4a ) the molecular structure differs from 2 only in the sulfonate group. Here, the CF 3 is directly joined to the sulfur rather than a CH 2 CF 3 group being joined to the sulfur. This has a pronounced influence on the interactions between molecules and hence the crystal packing. Coordination about the metal is similar to other examples. The N-H···Cl interactions from the bound ethylenediamine do not occur in this structure; one N-H···O=S hydrogen bond is present. There are N-H (amide)···Cl interactions that form dimers of molecules. These dimers are held into a puckered 2-D network by the N-H···O=S hydrogen bonds. The space between networks is filled by the anions. Compound 4 crystallizes in the monoclinic space group P21/n with two Ru complex ions and two PF6 − anions in the asymmetric unit (Z' = 2) ( Figure 4b ). The Zʹ = 2 structure persists at room temperature. There is small-scale disorder in the position of the carbons of the ethylenediamine ligand attached to Ru2. This corresponds to two different orientations of the carbon backbone. Each PF6 − anion is disordered over two positions. It was possible to identify these from the difference Fourier maps and model these groups using standard techniques. The crystal structure has Laue symmetry 2/m but it is twinned to mimic the Laue symmetry mmm. In terms of the unit cell, the primitive monoclinic structure is twinned to mimic a C-centered orthorhombic cell by the twin law that converts a, b, c into c, −b, a. This pseudo-merohedral twinning was allowed for in the refinement of the structure. The ratio of the major and minor components is 0.9680:0.0320 (7) . This led to a significant improvement in the quality of the fit on F 2 and an improvement in the C−C bond precision. Allowing for twinning, wR(F 2 ) (all data) decreased from 0.1562 to 0.1445 and the C−C precision improved from 0.0081 to 0.0073 Å. There are no classical hydrogen bonds present in the structure, but C−H···O and C−H···F interactions exists between the species present to generate a dense network of intermolecular interactions that extends in the 3-D.
5 crystallizes in the centric space group P21/n with a single ion pair in the asymmetric unit as shown in Figure 5 . As in previous examples there is a centric R 2 2(8) embrace formed from two N−H···Cl hydrogen bonds from ethylenediamine on adjacent molecules. Additionally, each molecule forms two more identical R 2 2(8) embraces to another molecule reflated by inversion, through the N−H(amide)···Cl and N−H(diamine)···O=S. These two sets of interactions produce tapes of molecules that run parallel to the crystallographic a direction. Between these tapes lie the PF6 − anions and there are C−H···F interactions present. Compound 4 crystallizes in the monoclinic space group P2 1 /n with two Ru complex ions and two PF 6 − anions in the asymmetric unit (Z = 2) ( Figure 4b ). The Z = 2 structure persists at room temperature. There is small-scale disorder in the position of the carbons of the ethylenediamine ligand attached to Ru2. This corresponds to two different orientations of the carbon backbone. Each PF 6 − anion is disordered over two positions. It was possible to identify these from the difference Fourier maps and model these groups using standard techniques. The crystal structure has Laue symmetry 2/m but it is twinned to mimic the Laue symmetry mmm. In terms of the unit cell, the primitive monoclinic structure is twinned to mimic a C-centered orthorhombic cell by the twin law that converts a, b, c into c, −b, a. This pseudo-merohedral twinning was allowed for in the refinement of the structure. The ratio of the major and minor components is 0.9680:0.0320 (7) . This led to a significant improvement in the quality of the fit on F 2 and an improvement in the C-C bond precision. Allowing for twinning, wR(F 2 ) (all data) decreased from 0.1562 to 0.1445 and the C−C precision improved from 0.0081 to 0.0073 Å.
There are no classical hydrogen bonds present in the structure, but C-H···O and C-H···F interactions exists between the species present to generate a dense network of intermolecular interactions that extends in the 3-D. 5 crystallizes in the centric space group P2 1 /n with a single ion pair in the asymmetric unit as shown in Figure 5 . As in previous examples there is a centric R 2 2 (8) embrace formed from two N-H···Cl hydrogen bonds from ethylenediamine on adjacent molecules. Additionally, each molecule forms two more identical R 2 2 (8) embraces to another molecule reflated by inversion, through the N-H(amide)···Cl and N-H(diamine)···O=S. These two sets of interactions produce tapes of molecules that run parallel to the crystallographic a direction. Between these tapes lie the PF 6 − anions and there are C-H···F interactions present.
shown in Figure 5 . As in previous examples there is a centric R 2 2(8) embrace formed from two N−H···Cl hydrogen bonds from ethylenediamine on adjacent molecules. Additionally, each molecule forms two more identical R 2 2(8) embraces to another molecule reflated by inversion, through the N−H(amide)···Cl and N−H(diamine)···O=S. These two sets of interactions produce tapes of molecules that run parallel to the crystallographic a direction. Between these tapes lie the PF6 − anions and there are C−H···F interactions present. At low temperature compound 6 crystallizes with two independent ruthenium complexes in the asymmetric unit and two hexafluorophosphate anions. At 100 K and 150 K, the structure crystallizes in space group Cc and has Z of 2 as shown in the ORTEP in Figure 6 . The coordination about the two ruthenium ions is very similar and the structure displays pseudo-symmetry, mimicking the higher symmetry space group C2/c. Adjacent pairs of independent complexes are held together by two N-H···Cl hydrogen bonds in a pseudo-centric R 2 2 (8) embrace. These dimers are further linked by the presence of N-H···O=C hydrogen bonds. This gives a dense network of complexes in 3-D within which are located the anions. At higher temperature the pseudo symmetry operation is replaced by a strict one and the structure crystallizes with a single ruthenium complex in the asymmetric unit in space group C2/c. The structure at 298 K is shown in Figure 6 . The same crystal was examined at 298 K and 100 K without being remounted. It is clear from refinements and comparisons of the bond precision at different temperatures that the true cell at low temperature has Z = 2 while that 298 K is Z = 1. This increase in symmetry with increase in temperature is common; one recent example shows two phase changes associated with increasing symmetry upon heating [19] . At 298 K the same packing of the complexes as the low temperature form is present, based on truly centrosymmetric hydrogen-bonded dimers. At low temperature compound 6 crystallizes with two independent ruthenium complexes in the asymmetric unit and two hexafluorophosphate anions. At 100 K and 150 K, the structure crystallizes in space group Cc and has Zʹ of 2 as shown in the ORTEP in Figure 6 . The coordination about the two ruthenium ions is very similar and the structure displays pseudo-symmetry, mimicking the higher symmetry space group C2/c. Adjacent pairs of independent complexes are held together by two N−H···Cl hydrogen bonds in a pseudo-centric R 2 2(8) embrace. These dimers are further linked by the presence of N−H···O=C hydrogen bonds. This gives a dense network of complexes in 3-D within which are located the anions. At higher temperature the pseudo symmetry operation is replaced by a strict one and the structure crystallizes with a single ruthenium complex in the asymmetric unit in space group C2/c. The structure at 298 K is shown in Figure 6 . The same crystal was examined at 298 K and 100 K without being remounted. It is clear from refinements and comparisons of the bond precision at different temperatures that the true cell at low temperature has Zʹ=2 while that 298 K is Zʹ=1. This increase in symmetry with increase in temperature is common; one recent example shows two phase changes associated with increasing symmetry upon heating [19] . At 298 K the same packing of the complexes as the low temperature form is present, based on truly centrosymmetric hydrogen-bonded dimers. 
Solution Studies
The ability of the tethered sulfonamide functionality to reversibly ligate to the ruthenium atom in a pH-dependent manner, forming an intramolecular chelate, was examined by recording 1 H NMR spectra of 1-5 (and 19 F NMR spectra for 2-5) (2.46 mM complex, D2O, 298 K, 0.1 M NaCl) as a function of pH. Within these spectra two unique sets of signals were observed, the relative proportion of these being pH-dependent, that were assigned to the open and chelate forms of the complexes (Figures S12-S15). Plotting the percentage of open form of the complex, calculated from the ratio of selected ligand signals corresponding to the open and chelate forms of the complexes, versus pD yielded sigmoidal curves in each case and apparent pKa values for 15 (Table 1) were determined by fitting of 
The ability of the tethered sulfonamide functionality to reversibly ligate to the ruthenium atom in a pH-dependent manner, forming an intramolecular chelate, was examined by recording 1 H NMR spectra of 1-5 (and 19 F NMR spectra for 2-5) (2.46 mM complex, D 2 O, 298 K, 0.1 M NaCl) as a function of pH. Within these spectra two unique sets of signals were observed, the relative proportion of these being pH-dependent, that were assigned to the open and chelate forms of the complexes (Figures S12-S15). Plotting the percentage of open form of the complex, calculated from the ratio of selected ligand signals corresponding to the open and chelate forms of the complexes, versus pD yielded sigmoidal curves in each case and apparent pK a values for 1-5 (Table 1) were determined by fitting of the Henderson-Hasselbalch equation to the data (Figures 7 and 8 ). The increasingly electron-withdrawing nature of the sulfonamide R substituent on going from 1-3 is reflected by the decrease in the apparent pKa values of 7.32, 6.41 and 4.50 respectivelyhighlighting the ability to modulate the basicity of the sulfonamide nitrogen through choice of R group. It is worthwhile comparing these apparent pKa values to those for the analogous [Ru(η 6 -C6H5CH2CH2NHR)(C2O4)(H2O)] complexes we have previously reported that bear oxalate ligands in place of the ethylenediamine ligand (Table 1, Figure 8 ) [15] . The presence of the dianionic oxalate ligand results in an apparent pKa value 0.45-0.67 pH units lower than in the analogous en complex and reflects the influence of increased electron density at the metal center on sulfonamide nitrogen coordination. The increasingly electron-withdrawing nature of the sulfonamide R substituent on going from 1-3 is reflected by the decrease in the apparent pK a values of 7.32, 6.41 and 4.50 respectively-highlighting the ability to modulate the basicity of the sulfonamide nitrogen through choice of R group. It is worthwhile comparing these apparent pK a values to those for the analogous [Ru(η 6 -C 6 H 5 CH 2 CH 2 NHR)(C 2 O 4 )(H 2 O)] complexes we have previously reported that bear oxalate ligands in place of the ethylenediamine ligand (Table 1, Figure 8 ) [15] . The presence of the dianionic oxalate ligand results in an apparent pK a value 0.45-0.67 pH units lower than in the analogous en complex and reflects the influence of increased electron density at the metal center on sulfonamide nitrogen coordination. A comparison of the apparent pKa values obtained for 3-5 shows that as the length of the tether between the arene ligand and the sulfonamide group increases the apparent pKa also increases (Appendix A, Table 1 , Figure 7) , likely reflecting the reduction in intramolecular chelate ring strain as tether length increases as well as the decreasing proximity of the sulfonamide nitrogen to the metal center.
During these studies it was observed that for 1-3 arene-ruthenium cleavage began to occur on standing of the NMR solution for even relatively short periods of time (>1 h) (Figures S12-S14). In contrast, arene loss was not observed with 4 and 5, even on standing for extended periods of time (>24 h), and most likely reflects the reduced ring strain experienced by the latter complexes when in their chelate form compared to 1-3 possessing a shorter tether. 1 H NMR spectra of 6 recorded as a function of pH did not reveal any pH-dependent behavior across the physiologically relevant pH region and the amide nitrogen was unable to coordinate to ruthenium under any of the conditions evaluated ( Figure S11) .
The coordination of a metallodrug, via the metal ion, to biomacromolecular targets is a major mechanism by which biological activity is exerted in many of these complexes. To evaluate the ability of intramolecular sulfonamide ligation to regulate the availability of a coordination site at the ruthenium ion in this family of complexes, and therefore control ligation of endogenous ligands to the complex, binding studies were performed between 4 (and the control compound 6) and the model ligands L-histidine and 5′-GMP. 4 and 6 were incubated with 1 eq. of 5′-GMP or L-histidine (2.46 mM complex, phosphate buffer (0.2 M), 310 K, 0.1 M NaCl) for 144 h at pD values of 7.5 and 6.5 in each case. Incubations were monitored by 1 H and 19 F NMR. Intramolecular sulfonamide ligation in 4 was found to regulate the coordination of 5′-GMP or L-histidine significantly compared to 6. For example, at a pD value of 7.5 no coordination of 5′-GMP or L-histidine to 4 was observed after 144 h incubation (Figures S16 and S19) and the sulfonamide group remained coordinated to ruthenium. In contrast, at a pD value of 6.5 5′-GMP was observed to be able to coordinate to 4-16 ± 1.6% (n = 4) of 5′-GMP was found to be coordinated after 144 h incubation ( Figure S17) , highlighting the increased proportion of the open form of 4 present in these pD conditions. These spectra also show very weak signals attributed to the release of minor quantities of free arene ligand, indicating that on coordination of A comparison of the apparent pK a values obtained for 3-5 shows that as the length of the tether between the arene ligand and the sulfonamide group increases the apparent pK a also increases (Appendix A, Table 1 , Figure 7) , likely reflecting the reduction in intramolecular chelate ring strain as tether length increases as well as the decreasing proximity of the sulfonamide nitrogen to the metal center.
The coordination of a metallodrug, via the metal ion, to biomacromolecular targets is a major mechanism by which biological activity is exerted in many of these complexes. To evaluate the ability of intramolecular sulfonamide ligation to regulate the availability of a coordination site at the ruthenium ion in this family of complexes, and therefore control ligation of endogenous ligands to the complex, binding studies were performed between 4 (and the control compound 6) and the model ligands L-histidine and 5 -GMP. 4 and 6 were incubated with 1 eq. of 5 -GMP or L-histidine (2.46 mM complex, phosphate buffer (0.2 M), 310 K, 0.1 M NaCl) for 144 h at pD values of 7.5 and 6.5 in each case. Incubations were monitored by 1 H and 19 F NMR. Intramolecular sulfonamide ligation in 4 was found to regulate the coordination of 5 -GMP or L-histidine significantly compared to 6. For example, at a pD value of 7.5 no coordination of 5 -GMP or L-histidine to 4 was observed after 144 h incubation (Figures S16 and S19) and the sulfonamide group remained coordinated to ruthenium. In contrast, at a pD value of 6.5 5 -GMP was observed to be able to coordinate to 4-16 ± 1.6% (n = 4) of 5 -GMP was found to be coordinated after 144 h incubation ( Figure S17) , highlighting the increased proportion of the open form of 4 present in these pD conditions. These spectra also show very weak signals attributed to the release of minor quantities of free arene ligand, indicating that on coordination of 5 -GMP to 4 under these conditions a further decomposition pathway may be established-similar decomposition was not observed in the incubations between 4 and 5 -GMP at pD 7.5 or 6 and 5 -GMP at pD values of 6.5 or 7.5. No coordination of L-histidine to 4 was observed at pD 6.5 ( Figure S20 ), even after 144 h incubation. 6, which possesses an arene-tethered amide group that does not ligate to ruthenium to form an intramolecular chelate, was found to be significantly more reactive toward 5 -GMP and L-histidine. 41% and 64% of 5 -GMP was found to coordinate to 6 at pD values of 7.5 and 6.5 respectively after 144 h incubation ( Figure S18 ). L-histidine was also found to coordinate to 6 under both pD conditions, as assessed by 1 H NMR ( Figure S21 ) and visualized through the darkening of the color of the solution -this was not observed with 4. The degree of L-histidine coordination was not able to be quantified using 1 H NMR due to hydrogen-deuterium exchange which occurs at the histidine C2 proton [21] and low intensity and overlapping peaks, but was more pronounced at pD 7.5 than pD 6.5. This is presumably due to appreciable L-histidine imidazole protonation under the latter conditions (side chain pK a = 6.07 [22] ) which contrasts with 5 -GMP where the N7 position (pK a = 2.57 [23] ) is not protonated across the pH range examined. We further incubated 4 with bovine serum albumin to the open-form within these equilibration reactions was found to be 177, 457 and 695 min at pD values of 4.12, 4.91 and 5.96 respectively. These results highlight that the activation of 4 through ring-opening of the intramolecular chelate is much faster in more acidic pH-conditions and indicates why the reaction of the complex with 5 -GMP at pD 6.1 was only observed after extended incubation times.
conditions equilibrium was not reached within 16 h -data fitting indicated that 61% and 24% of the open-form of 4 would be present at equilibrium in pD conditions of 4.91 and 5.96 respectively. The half-life for the fraction of the chelate-form of 4 which is converted to the open-form within these equilibration reactions was found to be 177, 457 and 695 min at pD values of 4.12, 4.91 and 5.96 respectively. These results highlight that the activation of 4 through ring-opening of the intramolecular chelate is much faster in more acidic pH-conditions and indicates why the reaction of the complex with 5′-GMP at pD 6.1 was only observed after extended incubation times. 
Evaluation of In Vitro Anticancer Activity
Having established the ability of 4 to coordinate to biologically relevant ligands in a pH-dependent manner we evaluated the cytotoxicity of 4 (and 6 as a control unable to form an intramolecular chelate) against the HT-29 cell line using the MTT assay. In light of the potential non-covalent interaction of 4 with protein as described earlier these assays were performed for both 4 and 6 using media containing 10% and 1% fetal calf serum to assess the effect of serum concentration on cytotoxicity. In each case no significant inhibition of cell growth was observed following cell exposure to the complexes at concentrations up to 100 µM for 72 h. It is clear that while 6 is readily able to coordinate to 5 -GMP and L-histidine, and presumably forms biomacromolecular adducts in cell culture experiments, the nature and/or level of adducts formed is not detrimental to HT-29 cell viability. The ability of 4 to form biomacromolecular adducts in cell culture conditions will be less than that of 6 due to substantial intramolecular sulfonamide ligation under these pH conditions. It is therefore not unexpected that 4 exhibits no cytotoxicity towards the HT-29 cell line. The lack of toxicity of 6 is surprising given that low IC 50 values (typically <20 µM) are well documented for the [Ru(η 6 -arene)(en)(Cl)]PF 6 family of compounds [17] , consequently further experiments are required to probe the origins of this behavior (such as uptake and intracellular localization studies) but the MTT assays indicate that this may not be due to deactivation through protein binding.
Conclusions
In summary, reversible intramolecular sulfonamide ligation has been extended to the [Ru(η 6 -arene)(en)(Cl)]PF 6 family of complexes and has been found to be an effective method of regulating the coordination environment at the central metal atom in a pH-dependent manner. Variation of the sulfonamide R group and the length of the tether linking the arene ligand and sulfonamide functionality was shown to modulate the apparent pK a of the sulfonamide proton, and hence the pH region over which regulation of metal coordination occurs. This was exemplified in 4 by the regulation of ruthenium coordination to model ligands and bovine serum albumin over the physiologically relevant pH region. However, the slow ring-opening of the chelate form of 4 to activate the complex is a limitation of these systems and would not enable complete activation/deactivation of the complex within a suitable timescale on transfer between the different pH environments within biological systems. The lack of cytotoxicity exhibited by 6, a complex expected to form appreciable levels of biomacromolecular adducts in cell culture experiments, was surprising and further experiments are required to uncover the origins of this behavior and to modify structural elements of these complexes so that in the open form they are as active as previously reported [(η 6 -arene)Ru(en)X] n+ compounds. For example, analogous complexes could be devised bearing extended planar arene ligands that would promote Ru-N7-guanine coordination in DNA, as reported for the [(η 6 -arene)Ru(en)X] n+ series of complexes [23] , and potentially lead to more potent complexes. The complexes reported within therefore provide a basis for the further development of potent anticancer compounds with pH-dependent reactivity profiles dictated by reversible intramolecular sulfonamide ligation.
Materials and Methods
Materials
All commercially purchased materials were used as received. Ethylenediamine, guanosine 5 -monophosphate disodium salt and ruthenium(III) chloride hydrate were purchased from Fluorochem Ltd. (Hadfield, UK). L-histidine was purchased from Acros Organics (Geel, Belgium). Silver carbonate was purchased from Alfa Aesar (Heysham, UK). Ammonium hexafluorophosphate, citric acid, deuterium chloride (20 wt. % solution in D 2 O), sodium deuteroxide (40 wt. % solution in D 2 O), sodium phosphate dibasic heptahydrate, sodium sulfate, trimethylamine and 2,2,2-trifluoroethanesulfonyl chloride were purchased from Fisher Scientific (Loughborough, UK). Dichloromethane, ethanol and methanol were purchased from Honeywell (Morristown, NJ, USA). Diethyl ether was purchased from VWR (Lutterworth, UK). Chloroform-d, dimethylsulfoxide-d 6 and deuterium oxide were purchased from Eurisotop (Saint-Aubin, France).
Instrumentation and Methods
NMR
1 H, 13 C and 19 F NMR spectra were recorded on a Jeol JEOL ECZ 400S spectrometer ( 1 H at 400.2 MHz, 13 C at 100.6 MHz and 19 F at 376.5 MHz) (Welwyn Garden City, UK). Spectra are referenced internally to residual solvent peaks (D 2 O: 1 H δ 4.79 ppm, 13 C δ unreferenced; DMSO-d 6 : 1 H δ 2.50 ppm, 13 C δ 39.52 ppm); 19 F NMR spectra are reported relative to a CFCl 3 reference (δ 0 ppm). Spectra were acquired at 295 K unless stated otherwise.
Mass Spectrometry
Accurate mass measurements were performed at the University of Hull using a Bruker Maxis Impact QqTOF MSMS (Coventry, UK). Before mass measurement the instrument was calibrated against sodium formate over the range 90 to 1550 Da. Resolution used was typically 45000. Samples (as solutions in methanol, 10-5 M) were injected into a solvent stream from a syringe pump at 3 µL min −1 via a 5 µL loop injector. The data was then internally mass measured against an internal calibrant peak from hexakis(1H,1H,4H-hexafluorobutyloxy)phosphazine (CAS No. 186406-47-2) C 24 H 18 O 6 N 3 P 3 F 36 m/z 1220.99064. An average result from 3-5 separate injections is quoted. The mass was measured and calculated using Bruker DataAnalysis 4.2 software (Coventry, UK).
GCMS. A Perkin-Elmer Autosystem XL GC coupled with a Perkin-Elmer Turbomass (Seer Green, UK) quadrupole MS was used, equipped with a Restek Rxi-1MS column 30 m (l) × 0.25 mm (i.d.) 0.25 µm film thickness. He was used as the carrier gas (mobile phase) at 1 mL·min −1 . A 1.0 µL sample injection volume with 20:1 split was employed. The scan range spanned m/z 600 to m/z 30 in 1 sec in conjunction with positive mode electron ionization at 70 eV.
X-ray Crystallography
Routine X-ray diffraction intensity data were collected in series of ω-scans using a Stoe IPDS2 image plate (Darmstadt, Germany) diffractometer operating with Mo Kα radiation at 150(2) K (290(2) K for 5 and 100(2) K for 6). The data were corrected for the effects of absorption using a multi-scan method [24] . The structures were solved using dual-space methods within SHELXT and full-matrix least squares refinement against F 2 was carried out within SHELXL-2014 or SHELXL-2018 via the WinGX program interface [25, 26] . All non-hydrogen positions were located in the direct and difference Fourier maps and refined using anisotropic displacement parameters. Hydrogen atoms were placed using a riding model. Crystal structure data for the compounds reported here are summarized in the ESI. Crystal structure data (CCDC 1963883, 1963884, 1963885, 1963886, 1963887, 1963888 and 1963889) are available free of charge from the CCDC via https://www.ccdc.cam.ac.uk/structures/.
Elemental Analysis
Elemental analysis was performed at the University of Hull. Analysis for all compounds was performed with the addition of V 2 O 5 .
Synthesis
[Ru(η 6 -1,1,1-trifluoro-N-phenethylmethanesulfonamide)Cl 2 ] 2 [27] , [Ru(η 6 -1,1,1-trifluoro-N-(3phenylpropyl)methanesulfonamide)Cl 2 ] 2 [27] , [Ru(η 6 -1,1,1-trifluoro-N-(4-phenylbutyl)methanesulfona mide)Cl 2 ] 2 [27] , [Ru(η 6 -N-phenethylacetamide)Cl 2 ] 2 [28] , [Ru(η 6 -N-phenethylmethanesulfonamide)Cl 2 ] 2 [15] and 2-(cyclohexa-1,4-dien-1-yl)ethan-1-amine [29] were synthesized as previously reported.
Complex 1:
[Ru(η 6 -N-phenethylmethanesulfonamide)Cl 2 ] 2 (200 mg, 0.269 mmol) was suspended in MeOH (40 mL) followed by the addition of ethylenediamine (36 µL, 0.537 mmol)-the mixture became slightly more soluble on stirring. After stirring for 2 h the reaction mixture was filtered followed by the addition of NH 4 PF 6 (262 mg, 1.61 mmol)-the mixture was stirred for 15 min then filtered and dried under reduced pressure. The residue was resuspended in MeOH (15 mL), filtered then the volume of the solution was concentrated under reduced pressure (~4 mL) and left to cool at 4 • C. After 24 h an oily dark solid had precipitated, this was isolated by decanting the liquid and dried under reduced pressure. The isolated solvent was left to stand at 4 • C for a further 24 h where further solid precipitated-this was isolated by decanting the liquid then was dissolved in MeOH (10 mL), combined with the first batch of solid isolated and stirred until the mixture had solubilized, filtered then the solvent volume was reduced to 5 mL under reduced pressure and left to stand at 4 • C. Dark red crystals formed over 48 h-these were isolated, washed with MeOH (0.5 mL) then dried under reduced pressure. The solid was then dissolved in H 2 O (2 mL) and lyophilized to remove residual MeOH and leave the product as a yellow powder (27 mg, 0.050 mmol, 9%). 1 
Complex 4:
[Ru(η 6 -1,1,1-trifluoro-N-(3-phenylpropyl)methanesulfonamide)Cl 2 ] 2 (177 mg, 0.202 mmol) was suspended in MeOH (40 mL) to yield a yellow suspension that turned green on the addition of ethylenediamine (40 µL, 0.598 mmol). The green suspension was stirred for 18 h then filtered to yield a yellow solution that was dried under reduced pressure. The residue was dissolved in MeOH (10 mL) followed by addition of Ag 2 CO 3 (222 mg, 0.805 mmol) to yield a dark suspension that was stirred for 18 h. The suspension was then filtered and NEt 3 (56 µL, 0.402 mmol) added to the dark orange solution followed by stirring for 20 min-the solution was filtered followed by the addition of NH 4 PF 6 (197 mg, 1.21 mmol), stirred for 5 min then filtered. The dark solution was concentrated under reduced pressure (~4 mL) then left to stand at 4 • C to yield an orange solid (69 mg, 0.121 mmol, 60%). 1 (s, 3F, CF 3 -); 13 
Complex 6:
[Ru(η 6 -N-phenethylacetamide)Cl 2 ] 2 (96 mg, 0.143 mmol) was suspended in methanol (30 mL) followed by the addition of ethylenediamine (19 µL, 0.284 mmol). This resulted in the solubilization of the bulk of the reaction mixture to form a straw-colored solution. After stirring for 1 h the reaction mixture was filtered followed by the addition of NH 4 PF 6 (139 mg, 0.853 mmol)-the mixture was stirred for 20 min then filtered and dried under reduced pressure. The yellow residue was resuspended in MeOH (8 mL), filtered then the volume of the solution was concentrated under reduced pressure (~2 mL) and left to cool at −18 • C. Crystals that formed over 5 days were collected, washed with EtOH (0.5 mL) then recrystallized by dissolution in hot EtOH (4 mL), filtering then cooling at −18 • C. After 24 h the solution was decanted from the solid which had formed, the solid washed with EtOH (1 mL) then dried under reduced pressure. The solid was then dissolved in water and lyophilized to remove residual solvent to leave the product as a yellow orange powder (40 mg, 0.079 mmol, 28%). 1 
